QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.082644v1 314/2/675    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Shannon, E. E. Articles by Grant, K. A. Search for Related Content PubMed PubMed Citation Articles by Shannon, E. E. Articles by Grant, K. A.

BEHAVIORAL PHARMACOLOGY

Characterization of the Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone in DBA/2J and C57BL/6J Inbred Mice

Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina (E.E.S., P.P., K.A.G.); Veterans Medical Research Foundation and the Department of Veterans Affairs Medical Center, San Diego, California (R.H.P.); and Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California (R.H.P.)

Neurosteroids represent a class of endogenous compounds that exert rapid, nongenomic effects through neurotransmitter receptor systems such as GABA_A. Two neurosteroids, allopregnanolone (3-hydroxy-5-pregnan-20-one) and pregnanolone (3-hydroxy-5-pregnan-20-one), possess anxiolytic and sedative properties and show substitution for ethanol, benzodiazepines, and barbiturates in drug discrimination assays. This study aimed to examine the effects of strain and sex on the discriminative stimulus effects of pregnanolone. Twelve male and female DBA/2J mice and 12 male and female C57BL/6J mice were trained to discriminate 10 mg/kg pregnanolone from saline. The male C57BL/6J mice had to be removed from the study due to increased seizures apparently associated with the chronic intermittent pregnanolone administration used in drug discrimination. GABA_A-positive modulators, neuroactive steroids, N-methyl-D-aspartate (NMDA) antagonists, and 5-hydroxytryptamine (5-HT)₃ agonists were tested for pregnanolone substitution. In DBA/2J and C57BL/6J mice, a benzodiazepine, barbiturate, and GABAergic neuroactive steroids all substituted for the stimulus effects of pregnanolone. NMDA antagonists, 5-HT₃ agonists, and zolpidem failed to substitute for pregnanolone's discriminative stimulus in either sex or strain. Pentobarbital and midazolam were more potent in producing pregnanolone-like discriminative stimulus effects in DBA/2J mice. Differences in sensitivities to neurosteroids between the two strains were not evident. These results provide a comprehensive look at pregnanolone's discriminative stimulus effects in two commonly used strains of mice. The present data suggest that many of the previously documented neurosteroid-induced behavioral differences between the DBA/2J and C57BL/6J are acute effects and are not apparent in a drug discrimination procedure.

Address correspondence to: Dr. Kathleen A. Grant, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1083. E-mail: kagrant{at}wfubmc.edu